Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
58 participants
OBSERVATIONAL
2024-04-01
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France -IMEA073
NCT07122557
Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France
NCT06799338
Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST
NCT03858478
Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts
NCT01928407
Cohort of Patients Naive of Antiretroviral Treatment at Enrollment
NCT03137797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Participant opposition to use of follow-up data
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint-Louis Hospital, Paris, France
OTHER
Bichat Hospital
OTHER
Saint Antoine University Hospital
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de la Côte Basque
Bayonne, France, France
Hôpital Béclère
Clamart, France, France
Hôpital de la Rochelle
La Rochelle, France, France
Hôpital Bicêtre
Le Kremlin-Bicêtre, France, France
Hôpital Max Fourestier
Nanterre, France, France
CHU La Source
Orléans, France, France
Hôpital Félix Guyon
Saint-Denis, LA Reunion, France
Hopital Zobda Quitman
Fort-de-France, Martinique, France
Hopital Avicenne
Bobigny, , France
Hôpital Pellegrin - Service de Médecine Interne et Maladies Infectieuses
Bordeaux, , France
Hopital Saint-Andre
Bordeaux, , France
Hopital Raymond Poincare
Garches, , France
C.H.D de Vendee
La Roche-sur-Yon, , France
André Mignot Hospital
Le Chesnay, , France
Centre Hospitalier Bretagne Sud - Hôpital du Scorff
Lorient, , France
CHU de Nice
Nice, , France
Hôpital Hotel Dieu
Paris, , France
Hopital Saint Antoine
Paris, , France
Groupe Hospitalier Pitié-Salpêtrière - Service de Maladies Infectieuses et Tropicales
Paris, , France
Hopital Necker
Paris, , France
Bichat Hospital
Paris, , France
Delafontaine
Saint-Denis, , France
Hopital Foch
Suresnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMEA 070
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.